Sophia Genetics (SOPH) - Revenue and Sales Volume

SOPHiA GENETICS SA (SOPH) possesses a powerful network effect driven by an extensive array of oncology patient data. Revenues are based on clinic subscriptions to cloud software for genetic analysis. The company's annual sales volume clearly confirms the revenue trend, while 0.09 indicates the current level. However, the slow implementation of systems in medical centers and cyber threats are hindering business expansion.

The SOPHiA GENETICS SA (SOPH) business model is based on providing IT tools for high-precision diagnostics. By analyzing corporate sales dynamics, one can track the company's actual pace of commercial expansion. This indicator aggregates daily revenue, allowing market noise to be filtered out from the fundamental growth trend. Since demand for genetic analysis is non-cyclical, any deviations here reflect only changes in medical center budgets. The steady ascent of this metric confirms the stability of the capitalization.